Brooklyn, NY, United States of America

Brandon Carney

This inventor holds 1 USPTO granted patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2019.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Brandon Carney

Introduction

Brandon Carney is an accomplished inventor based in Brooklyn, NY. He has made significant contributions to the field of targeted diagnostics and therapeutics, particularly in cancer treatment. His innovative work has the potential to improve the lives of many patients facing challenging health conditions.

Latest Patents

Brandon Carney holds a patent for "Radiohalide-labeled targeted diagnostics and therapeutics." This patent discloses chemical entities of formula (I), wherein R, Rand n are defined. These chemical entities serve as radiative emitters and are useful as therapeutic agents for treating cancers, especially those in which PARP1 is overexpressed. His work in this area represents a significant advancement in cancer diagnostics and treatment.

Career Highlights

Brandon Carney is affiliated with the Memorial Sloan Kettering Cancer Center, where he continues to push the boundaries of medical research. His dedication to innovation in the field of cancer therapy has garnered attention and respect from his peers.

Collaborations

Brandon has collaborated with notable colleagues, including Thomas Reiner and Jason S. Lewis. These partnerships have further enhanced his research and development efforts in targeted cancer therapies.

Conclusion

Brandon Carney's contributions to the field of targeted diagnostics and therapeutics exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in cancer treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…